JM
Therapeutic Areas
Vericel Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MACI | Symptomatic cartilage defects of the knee (adults) | Approved |
| Epicel | Deep dermal or full-thickness burns ≥30% TBSA | Approved |
| NexoBrid | Eschar removal in adults with deep partial- and/or full-thickness thermal burns | Approved |
| Next-Generation Burn Care Program | Severe Burns | Research/Preclinical |